CytomX Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of CytomX Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-07 | $0.07 | $-0.17 | 141.2 % |
Jun 2024 | 2024-08-08 | $-0.08 | $-0.14 | 42.9 % |
Mar 2024 | 2024-05-08 | $0.17 | $-0.06 | 383.3 % |
Dec 2023 | 2024-03-11 | $0.01 | $-0.03 | 133.3 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-07 | $33.43M | $17.51M | 90.9 % |
Jun 2024 | 2024-08-08 | $25.12M | $19.99M | 25.6 % |
Mar 2024 | 2024-05-08 | $41.46M | $22.02M | 88.3 % |
Dec 2023 | 2024-03-11 | $26.61M | $21.04M | 26.5 % |
CytomX Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3.
CytomX Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3 and the Actual EPS was $0.07, which beat the estimate of $-0.17.
CytomX Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.